News & Updates

Modified dual therapy on par with recommended regimen in H. pylori infection
Modified dual therapy on par with recommended regimen in H. pylori infection
28 Oct 2021

A modified dual therapy as first-line treatment for H. pylori infection demonstrates equal efficacy and compliance relative to recommended regimens, reveals a study. Moreover, a generally modified dual therapy has fewer side effects.

Modified dual therapy on par with recommended regimen in H. pylori infection
28 Oct 2021
Dietary ALA intake may lower risks of all-cause, CVD, CHD mortality
Dietary ALA intake may lower risks of all-cause, CVD, CHD mortality
28 Oct 2021 byStephen Padilla

Dietary intake of alpha linolenic acid (ALA) appears to reduce the risk of mortality from all causes, cardiovascular disease (CVD), and coronary heart disease (CHD) but may slightly increase the risk of cancer mortality, according to a systematic review and meta-analysis. Moreover, an association exists between higher blood levels of ALA and a lower risk of all-cause and CHD mortality.

Dietary ALA intake may lower risks of all-cause, CVD, CHD mortality
28 Oct 2021
Healthy diet can improve well-being of adults with multiple sclerosis
Healthy diet can improve well-being of adults with multiple sclerosis
28 Oct 2021

A healthier overall diet score and higher fibre, fruit, and vegetable scores result in better health outcomes in adults with multiple sclerosis (MS), according to a study, noting a much lower proportion of participants avoiding dairy and meat or adhering to a specific MS diet than previously reported.

Healthy diet can improve well-being of adults with multiple sclerosis
28 Oct 2021
Online symptom checkers unreliable for COVID-19 triage
Online symptom checkers unreliable for COVID-19 triage
28 Oct 2021 byTristan Manalac

Though promising, coronavirus disease 2019 (COVID-19) symptom checkers—online, patient-led triage systems—are unable to reliably distinguish mild from severe COVID-19 and may instead put the public and healthcare workers at greater risk of infection, according to a recent study.

Online symptom checkers unreliable for COVID-19 triage
28 Oct 2021
Polypharmacy in T2D may increase susceptibility to bone fractures
Polypharmacy in T2D may increase susceptibility to bone fractures
28 Oct 2021

Type 2 diabetes (T2D) patients who are taking multiple medications together are at heightened risk of bone fractures, a study has found.

Polypharmacy in T2D may increase susceptibility to bone fractures
28 Oct 2021
Kidney disease linked to modest risk of dementia
Kidney disease linked to modest risk of dementia
28 Oct 2021
Adjuvant atezolizumab improves DFS in early-stage NSCLC
Adjuvant atezolizumab improves DFS in early-stage NSCLC
27 Oct 2021 byRoshini Claire Anthony

In patients with completely resected stage II–IIIA non-small-cell lung cancer (NSCLC) who had previously received adjuvant cisplatin chemotherapy, adjuvant atezolizumab extended disease-free survival (DFS), particularly in those with PD-L1 expression 1 percent on tumour cells, interim results of the phase III IMpower010 trial showed.

Adjuvant atezolizumab improves DFS in early-stage NSCLC
27 Oct 2021
Overweight, obesity during pregnancy up offspring’s NAFLD risk
Overweight, obesity during pregnancy up offspring’s NAFLD risk
27 Oct 2021